X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (93) 93
index medicus (92) 92
rheumatoid arthritis (52) 52
rheumatology (52) 52
male (43) 43
arthritis, rheumatoid - drug therapy (42) 42
female (40) 40
middle aged (39) 39
treatment outcome (37) 37
adult (35) 35
antirheumatic agents - therapeutic use (32) 32
double-blind (30) 30
immunology (27) 27
care and treatment (25) 25
therapy (25) 25
aged (24) 24
arthritis (24) 24
methotrexate (24) 24
rheumatoid factor (20) 20
antirheumatic agents - administration & dosage (18) 18
antirheumatic agents - adverse effects (18) 18
rituximab (18) 18
abridged index medicus (16) 16
disease (16) 16
drug therapy, combination (16) 16
safety (16) 16
severity of illness index (16) 16
cytokines (15) 15
inflammation (15) 15
tnf inhibitors (15) 15
tumor necrosis factor-tnf (15) 15
analysis (14) 14
drug therapy (14) 14
modifying antirheumatic drugs (14) 14
patients (14) 14
clinical trials (13) 13
1506 (12) 12
inadequate response (12) 12
interleukin-6 receptor inhibition (12) 12
aids/hiv (11) 11
dmards (11) 11
double-blind method (11) 11
musculoskeletal diseases (11) 11
skin and connective tissue diseases (11) 11
antibodies, monoclonal - therapeutic use (10) 10
arthritis, rheumatoid - immunology (10) 10
efficacy (10) 10
etanercept (10) 10
methotrexate - therapeutic use (10) 10
antibodies, monoclonal, humanized - adverse effects (9) 9
antirheumatic agents (9) 9
infection (9) 9
medicine & public health (9) 9
pathogenesis (9) 9
research (9) 9
retrospective studies (9) 9
studies (9) 9
time factors (9) 9
tumor necrosis factor (9) 9
tumor necrosis factor-alpha - antagonists & inhibitors (9) 9
adalimumab (8) 8
diagnosis (8) 8
disease progression (8) 8
expression (8) 8
lymphocytes (8) 8
review (8) 8
risk factors (8) 8
treatment (8) 8
antibodies, monoclonal, humanized - administration & dosage (7) 7
antibodies, monoclonal, humanized - therapeutic use (7) 7
c-reactive protein (7) 7
clinical and epidemiological research (7) 7
drug administration schedule (7) 7
drugs (7) 7
health aspects (7) 7
interleukin-6 (7) 7
internal medicine (7) 7
management (7) 7
medicine, research & experimental (7) 7
monoclonal antibodies (7) 7
placebo-controlled trial (7) 7
psoriasis (7) 7
quality of life (7) 7
rheumatic diseases (7) 7
systemic lupus erythematosus (7) 7
tocilizumab (7) 7
trial (7) 7
usage (7) 7
aids (6) 6
animals (6) 6
autoantibodies (6) 6
autoimmune diseases (6) 6
cd4-positive t-lymphocytes - virology (6) 6
cells (6) 6
disease-activity (6) 6
dosage and administration (6) 6
dose-response relationship, drug (6) 6
drug dosages (6) 6
epidemiology (6) 6
hiv (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of the Rheumatic Diseases, ISSN 0003-4967, 03/2014, Volume 73, Issue 3, pp. 492 - 509
Journal Article
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 01/2014, Volume 73, Issue 1, pp. 69 - 74
Journal Article
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 06/2018, Volume 391, Issue 10139, pp. 2513 - 2524
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 07/2015, Volume 74, Issue 7, pp. 1474 - 1478
ObjectivesTo investigate whether bortezomib, a proteasome inhibitor approved for treatment of multiple myeloma, induces clinically relevant plasma cell (PC)... 
CARFILZOMIB | THERAPY | DOSE DEXAMETHASONE | MEMORY | REJECTION | DISEASE | NEPHRITIS | RELAPSED MULTIPLE-MYELOMA | MICE | RHEUMATOLOGY | Humans | Pyrazines - administration & dosage | Lupus Erythematosus, Systemic - metabolism | Male | Pyrazines - therapeutic use | Boronic Acids - therapeutic use | Plasma Cells - pathology | Plasma Cells - drug effects | Lupus Erythematosus, Systemic - drug therapy | Lupus Erythematosus, Systemic - immunology | Interferon Type I - metabolism | Adult | Female | Boronic Acids - administration & dosage | Drug Therapy, Combination | Severity of Illness Index | Bortezomib | Dexamethasone - administration & dosage | DNA - immunology | Proteasome Inhibitors - pharmacology | Proteasome Inhibitors - administration & dosage | Treatment Outcome | Proteasome Inhibitors - therapeutic use | Administration, Intravenous | Dexamethasone - therapeutic use | Antibodies - blood | Pyrazines - pharmacology | Germany | Boronic Acids - pharmacology | Complications and side effects | Treatment outcome | Systemic lupus erythematosus | Analysis | Multiple myeloma | Dosage and administration | Drug therapy | Risk factors | Lupus | Studies | Immunoglobulins | Protease inhibitors | Disease | Bone marrow | Vaccines | Index Medicus | Systemic Lupus Erythematosus | Autoimmunity | Treatment | Autoimmune Diseases | Basic and Translational Research | B cells | 1506
Journal Article